APTARGROUP, INC.

AptarGroup, Inc. (NYSE: ATR) is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The company operates through three reportable segments serving diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care and home care. More information is available at www.aptar.com.

The Pharma segment represents approximately 46 percent of net sales and serves the prescription drug, consumer health care, injectables and active material science markets. This segment supplies nasal drug delivery spray pumps, metered dose inhaler valves, elastomeric primary packaging components for injectable applications, and digital health solutions that support patient treatment adherence and disease management across therapeutic areas including pulmonary, oncology, neurology, diabetes and immunology.

The Beauty segment accounts for approximately 35 percent of net sales and sells dispensing pumps, airless systems and valves to fragrance, color cosmetics, facial skincare and personal care markets. The Closures segment comprises approximately 19 percent of net sales and primarily sells dispensing closures and food service trays to food, beverage and personal care markets.

AptarGroup operates approximately 5,000 customers with no single customer representing more than four percent of annual net sales. The company maintains manufacturing facilities throughout North America, Europe, Asia and Latin America with approximately 14,000 full-time employees globally. Europe represents the largest geographic region for sales at approximately 49 percent of consolidated sales, while Asia and Latin America combined represent approximately 20 percent.

The company leverages proprietary design, engineering, materials science and manufacturing capabilities including injection molding, robotics, clean-room facilities and elastomer formulation expertise. AptarGroup has built competitive advantages through consistent innovation, quality, regulatory expertise, geographic diversity and a broad product portfolio. The company has validated science-based targets through the Science Based Targets Initiative for emissions reductions and maintains a Platinum Sustainability Rating with EcoVadis. Recent acquisitions and investments include Sommaplast, BTY and Goldrain, which strengthen the company's technology platforms and geographic reach.